Key information made simple
This summary needs review. Please check the official study record and contact the research team for details.
CompletedNCT01106430
Time to Response of Lisdexamfetamine Dimesylate to Atomoxetine Hydrochloride for ADHD
This study is completed in the United States, in Canada, in the United Kingdom, .... It is testing time to Response of Lisdexamfetamine Dimesylate to Atomoxetine Hydrochloride for ADHD.
ADHDDrugFrom 6 Years to 17 Years
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Then choose your country and confirm availability with each study site.
Check the study details
Check the official source, then confirm these points with the research team.
View official study record (opens in a new tab)
Questions to ask before joining
- What are the exact eligibility criteria, and what could exclude someone?
- How many visits, assessments, or follow-ups are expected, and over what period?
- What risks, side effects, practical burdens, or alternatives should be understood first?
- Who should be contacted to confirm locations, timing, compensation, and next steps?
Things to check before joining
Study start dateStarted: June 28, 2010
- Recruitment status
- Completed
- Enrollment listed in the registry
- 267
- Sponsor
- Shire
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States, Canada, United Kingdom, ...
- Age range
- From 6 Years to 17 Years
- Official registry ID
- NCT01106430
- Official title
- A Phase 3b, Double-blind, Randomised, Active-controlled, Parallel Group Study to Assess the Time to Response of Lisdexamfetamine Dimesylate to Atomoxetine Hydrochloride in Children and Adolescents Aged 6-17 Years With Attention-Deficit/Hyperactivity Disorder (ADHD) Who Have Had an Inadequate Response to Methylphenidate Therapy
Ask HopeStage to help me review this study
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Study ID: NCT01106430. We help you review the study, but cannot decide medical eligibility.
Check recruitment and locations
Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.
View official study record (opens in a new tab)The overall study status can differ from each site's status. Open a country to see its locations and their registry status.
Belgium · 2 sites
- ZiekenhuisNetwerk AntwerpenHoboken, AntwerpenSite status: Not listed — confirm with the team
- Universitair Ziekenhuis GasthuisbergLeuven, Flemish BrabantSite status: Not listed — confirm with the team
Canada · 5 sites
- Child and Adolescent CentreEdmonton, AlbertaSite status: Not listed — confirm with the team
- Centre for Anxiety Attention Deficit and TraumaHamilton, OntarioSite status: Not listed — confirm with the team
- AK Karan Holdings, Ltd.Oakville, OntarioSite status: Not listed — confirm with the team
- The Kids ClinicWhitby, OntarioSite status: Not listed — confirm with the team
- University of SaskatchewanSaskatoon, SaskatchewanSite status: Not listed — confirm with the team
Germany · 6 sites
- Albert-Ludwigs-Universitat FreiburgFreiburg im Breisgau, Baden-WurttembergSite status: Not listed — confirm with the team
- Zentralinstitut für Seelische Gesundheit MannheimMannheim, Baden-WurttembergSite status: Not listed — confirm with the team
- Schwerpunktpraxis für Entwicklung und LernenBamberg, BavariaSite status: Not listed — confirm with the team
- Medizinisches Studienzentrum WürzburgWürzburg, BavariaSite status: Not listed — confirm with the team
- Klinikum Frankfurt/OderFrankfurt (Oder), BrandenburgSite status: Not listed — confirm with the team
- Praxis Dr. WolffHagen, North Rhine-WestphaliaSite status: Not listed — confirm with the team
Hungary · 4 sites
- Szegedi Tudományegyetem Gyermek es lfjusagpszichlatrlai OsztalySzeged, Csongrád megyeSite status: Not listed — confirm with the team
- Vadaskert Korhaz es Szakambulancia Gyermek es lfjusagpszichiatriaBudapestSite status: Not listed — confirm with the team
- Bekes Megyei Kepviselotestulet Pandy Kalman KorhazaGyulaSite status: Not listed — confirm with the team
- Gyermek- es lfjusagpszichiatriai Szakrendeles es GondozoPécsSite status: Not listed — confirm with the team
Italy · 1 site
- Azienda Ospedaliero-Universitaria di CagliariCagliariSite status: Not listed — confirm with the team
Poland · 2 sites
- Katedra i Klinika PsychiatariiBydgoszcz, Kuyavian-Pomeranian VoivodeshipSite status: Not listed — confirm with the team
- Samodzielny Publiczny Dzieciecy Szpital KlinicznyWarsaw, Masovian VoivodeshipSite status: Not listed — confirm with the team
Spain · 6 sites
- Hospital Son LlàtzerPalma de Mallorca, Balearic IslandsSite status: Not listed — confirm with the team
- Hospital Sant Joan de DeuEsplugues de Llobregat, BarcelonaSite status: Not listed — confirm with the team
- Hospital Marítimo, Unidad de Salud Mental Infanto-Juvenil (USMI-JTorremolinos, MalagaSite status: Not listed — confirm with the team
- Hospital Universitario de CanariasSan Cristóbal de La Laguna, Santa Cruz De TenerifeSite status: Not listed — confirm with the team
- Complejo Hospitalario Universitario de BadajozBadajozSite status: Not listed — confirm with the team
- Hospital Clinic i Provincial de BarcelonaBarcelonaSite status: Not listed — confirm with the team
Sweden · 2 sites
- Drottning Silvias BarnsjukhusGothenburgSite status: Not listed — confirm with the team
- Astrid Lindgren Children's Hospital/Karolinska University HospitalStockholmSite status: Not listed — confirm with the team
United Kingdom · 2 sites
- Basildon HospitalBasildon, EssexSite status: Not listed — confirm with the team
- Tayside Children's HospitalDundee, ScotlandSite status: Not listed — confirm with the team
United States · 34 sites
- Harmonex Neuroscience Research, IncDothan, AlabamaSite status: Not listed — confirm with the team
- Clinical Study Centers, LLCLittle Rock, ArkansasSite status: Not listed — confirm with the team
- Shanti Clinical TrialsColton, CaliforniaSite status: Not listed — confirm with the team
- Psychiatric Centers at San Diego Feighner ResearchSan Diego, CaliforniaSite status: Not listed — confirm with the team
- Elite Clinical Trials, Inc.Wildomar, CaliforniaSite status: Not listed — confirm with the team
- Sarkis Clinical TrialsGainesville, FloridaSite status: Not listed — confirm with the team
- Amedica Research Institute, Inc.Hialeah, FloridaSite status: Not listed — confirm with the team
- Fidelity Clinical Research, Inc.Lauderhill, FloridaSite status: Not listed — confirm with the team
- Clinical Neuroscience Solutions, INCOrlando, FloridaSite status: Not listed — confirm with the team
- Northwest Behavioral Research CenterRoswell, GeorgiaSite status: Not listed — confirm with the team
- Capstone Clinical ResearchLibertyville, IllinoisSite status: Not listed — confirm with the team
- Baber Psychiatric AssociatesNaperville, IllinoisSite status: Not listed — confirm with the team
- ClincoTerre Haute, IndianaSite status: Not listed — confirm with the team
- Heartland Research Associates, LLCWichita, KansasSite status: Not listed — confirm with the team
- Four Rivers Clinical Research, IncPaducah, KentuckySite status: Not listed — confirm with the team
- Louisianna Research AssociatesNew Orleans, LouisianaSite status: Not listed — confirm with the team
- Office of Marc Hertzman, MD, PCRockville, MarylandSite status: Not listed — confirm with the team
- Rochester Center for Behavioral MedicineRochester Hills, MichiganSite status: Not listed — confirm with the team
- Midwest Research Group/Saint Charles Psychiatric AssociatesSaint Charles, MissouriSite status: Not listed — confirm with the team
- Premier Psychiatric Research Institute, LLCLincoln, NebraskaSite status: Not listed — confirm with the team
- Center for Psychiatry and Behavioral Medicine, Inc.Las Vegas, NevadaSite status: Not listed — confirm with the team
- Children's Specialized HospitalToms River, New JerseySite status: Not listed — confirm with the team
- Richmond Behavioral AssociatesStaten Island, New YorkSite status: Not listed — confirm with the team
- Triangle Neuropsychiatry, PLLCDurham, North CarolinaSite status: Not listed — confirm with the team
- Innovis HealthFargo, North DakotaSite status: Not listed — confirm with the team
- IPS Research CompanyOklahoma City, OklahomaSite status: Not listed — confirm with the team
- Cyn3rgy ResearchGresham, OregonSite status: Not listed — confirm with the team
- CRI Worldwide, LLC Kirkbride DivisionPhiladelphia, PennsylvaniaSite status: Not listed — confirm with the team
- Future Search Clinical TrialsAustin, TexasSite status: Not listed — confirm with the team
- Red Oak Psychiatry Association, PAHouston, TexasSite status: Not listed — confirm with the team
- Western Clinical InvestigationsLubbock, TexasSite status: Not listed — confirm with the team
- Cerebral Research, LLCSan Antonio, TexasSite status: Not listed — confirm with the team
- Lifetree Clinical ResearchSalt Lake City, UtahSite status: Not listed — confirm with the team
- Eastside Therapeutic ResourceKirkland, WashingtonSite status: Not listed — confirm with the team
For you
Participation may contribute to research. Personal benefit is not guaranteed.
Ask the research team to explain the activities, time commitment, and follow-up involved.
Study sites are listed. Confirm the relevant site and any travel before making plans.
Not medical advice
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
Questions about this study
What is this study trying to understand?
This study is exploring medication or study treatment for people with adhd. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.
Does this study involve a medication?
This appears to be a medication / drug study involving Lisdexamfetamine Dimesylate, Atomoxetine Hydrochloride. Phase 3 studies are usually larger and aim to confirm effectiveness and safety in a broader group.
Who might this study be for?
This study may concern people with adhd; age range: From 6 Years to 17 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.
What would I likely need to do?
You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
What side effects, interactions, or treatment changes should I check?
If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by Shire, which appears to be unknown or unclear. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meExplore related studies
Other studies that may be relevant based on condition, country, or study type.
CompletedNCT03785223
Methylphenidate Hydrochloride Controlled Release Capsules for ADHD
This study is completed in Canada. It is testing methylphenidate Hydrochloride Controlled Release Capsules for ADHD.
CompletedEUCTR 2010-021533-31
A 40-week, randomized, double-blind, placebo-controlled, multicenter efficacy and safety study of Ritalin® LA in the treatment of adult patients with childhood-onset ADHD
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
CompletedNCT02059642
MG01CI 1400 mg Compared With Placebo for ADHD
This study is completed in the United States and in Israel. It is testing MG01CI 1400 mg Compared With Placebo for ADHD.